Final height and craniofacial development after surgical resection of craniopharyngioma.
Seventeen patients (twelve males and five females) with craniopharyngioma were studied by retrospective review (stature, bone age, and hormone therapy) and by follow-up assessment in all seventeen survivors (stature and craniofacial development). Roentgencephalometric films in the lateral and frontal projections were analyzed. Individual and mean facial diagrams were produced based on 221 reference points in the individual patients and compared to normative data. The posterior cranial base was significantly reduced in length and the cranial base angle was significantly increased. In the facial regions great variations in size and prognathy of the jaws were recorded; on average the patients' maxilla and especially the mandible were short and retrognathic in relation to the anterior cranial base when compared to average adults. Average size and shape of the calvaria, cranial base, and facial regions in the adult male craniopharyngioma group corresponded closely to the average male at the stage of maximum growth in body height, i.e., around 14 years of age. It was concluded that size and morphology of the sphenoid and basioccipital bones were severely affected, possibly as a result of the interfering growth of a craniopharyngioma in childhood. The retrusion of the facial regions might be present as a result of the flattening of the posterior cranial base, but the relatively short and retruded mandible could also be caused by growth hormone deficiency before diagnosis/operation and in periods of sub-optimal therapy. The close resemblance of craniofacial morphology between adult males with craniopharyngioma and normal boys at the time of peak height velocity might reflect the fact that imitation of the natural, optimal balance between growth hormone and sex steroid in puberty is difficult to obtain in therapy.
Jensen
B L
BL
School of Dentistry, University of Copenhagen, Denmark.
Jensen
K E
KE
Kastrup
K W
KW
Pedersen
S A
SA
Wagner
A
A
D000293:Adolescent; D000328:Adult; D001827:Body Height; D002508:Cephalometry; D002648:Child; D019465:Craniofacial Abnormalities / Q000503:physiopathology*; D003397:Craniopharyngioma / Q000150:complications* / Q000503:physiopathology / Q000601:surgery; D003718:Denmark; D015914:Estrogen Replacement Therapy; D005147:Facial Bones / Q000254:growth & development* / Q000503:physiopathology; D005260:Female; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications* / Q000503:physiopathology / Q000601:surgery
D019382:Human Growth Hormone